D-1836-2019 Class II Terminated
FDA drug recall D-1836-2019 was initiated by Upsher Smith Laboratories, Inc. on Jul 29, 2019 and is designated Class II. Reason for recall: Failed Dissolution Specifications The recall status is terminated (terminated Aug 25, 2022). Affected quantity: 166 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 28, 2019
- Initiation Date
- Jul 29, 2019
- Termination Date
- Aug 25, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 166 bottles
Product description
Bexarotene Capsules, 75 mg, 100 capsules per bottle, Rx Only, Manufactured for: Upsher-Smith Laboratories, LLC, Maple Grove, MN 55369. NDC: 0832-0285-00
Reason for recall
Failed Dissolution Specifications
Distribution pattern
KY, OH, NJ, LA
Code information
Lot: A2610. exp 3/2020
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1836-2019
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026